Mammalian target of rapamycin (mTOR) inhibition reduces cerebral vasospasm following a subarachnoid hemorrhage injury in canines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mammalian target of rapamycin (mTOR) inhibition reduces cerebral vasospasm following a subarachnoid hemorrhage injury in canines

Published:2012-02 Issue:2 Volume:233 Page:799-806
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Zhang Weiguang,Khatibi Nikan H.,Yamaguchi-Okada Mitsuo,Yan Junhao,Chen Chunhua,Hu Qin,Meng Haiwei,Han Hongbin,Liu Shuwei,Zhou Changman

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference22 articles.

1. SAH-induced cerebral vasospasm: unraveling molecular mechanisms of a complex disease;Bhardwaj;Stroke,2003

2. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage;Borel;Stroke,2003

3. Mechanisms of mTOR inhibitor resistance in cancer therapy;Carew;Target. Oncol.,2011

4. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity;Chresta;Cancer Res.,2010

5. The mTOR pathway: a new target in cancer therapy;Ciuffreda;Curr. Cancer Drug Targets,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of Extracellular Electrical Properties with Tracer-Based MRI;Sensing and Imaging;2024-06-13

2. The Neuroprotective Effects and Probable Mechanisms of Everolimus in a Rat Model of Intracerebral Hemorrhage;Cellular and Molecular Neurobiology;2023-09-25

3. DTI-ALPS: An MR biomarker for motor dysfunction in patients with subacute ischemic stroke;Frontiers in Neuroscience;2023-03-31

4. FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders;Pharmaceuticals;2022-12-13

5. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): Relevant signaling pathways and therapeutic strategies;Frontiers in Immunology;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3